P.M.J. Haffmans

1.8k total citations
44 papers, 1.2k citations indexed

About

P.M.J. Haffmans is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, P.M.J. Haffmans has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 20 papers in Experimental and Cognitive Psychology and 18 papers in Pharmacology. Recurrent topics in P.M.J. Haffmans's work include Treatment of Major Depression (18 papers), Bipolar Disorder and Treatment (8 papers) and Mental Health Research Topics (8 papers). P.M.J. Haffmans is often cited by papers focused on Treatment of Major Depression (18 papers), Bipolar Disorder and Treatment (8 papers) and Mental Health Research Topics (8 papers). P.M.J. Haffmans collaborates with scholars based in Netherlands, United States and South Africa. P.M.J. Haffmans's co-authors include Erik Hoencamp, Linda Booij, Willem van der Does, Vincent M. Hendriks, Paul A. F. Jansen, Philip Spinhoven, Ingmar H. A. Franken, Willem A. Nolen, Paul F. Bouvy and Hugo J. Duivenvoorden and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

P.M.J. Haffmans

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.M.J. Haffmans Netherlands 20 455 359 341 221 203 44 1.2k
J.C. Ballenger United States 17 555 1.2× 273 0.8× 426 1.2× 328 1.5× 214 1.1× 174 1.7k
Nicholas DeMartinis United States 18 272 0.6× 542 1.5× 294 0.9× 210 1.0× 240 1.2× 35 1.1k
Anthony S. Hale United Kingdom 19 405 0.9× 237 0.7× 373 1.1× 230 1.0× 179 0.9× 46 1.3k
Maurizio Fava United States 13 461 1.0× 414 1.2× 536 1.6× 165 0.7× 227 1.1× 17 1.2k
Jun Ishigooka Japan 24 757 1.7× 215 0.6× 291 0.9× 167 0.8× 223 1.1× 123 1.6k
Peter D. Londborg United States 14 344 0.8× 599 1.7× 496 1.5× 423 1.9× 217 1.1× 19 1.2k
Ion Anghelescu Germany 21 557 1.2× 225 0.6× 360 1.1× 320 1.4× 235 1.2× 54 1.6k
J M Perel United States 21 433 1.0× 263 0.7× 331 1.0× 450 2.0× 195 1.0× 31 1.3k
Charles S. Wilcox United States 16 275 0.6× 272 0.8× 320 0.9× 171 0.8× 135 0.7× 27 806
Gustavo Kinrys United States 25 614 1.3× 546 1.5× 472 1.4× 474 2.1× 325 1.6× 52 1.9k

Countries citing papers authored by P.M.J. Haffmans

Since Specialization
Citations

This map shows the geographic impact of P.M.J. Haffmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M.J. Haffmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M.J. Haffmans more than expected).

Fields of papers citing papers by P.M.J. Haffmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M.J. Haffmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M.J. Haffmans. The network helps show where P.M.J. Haffmans may publish in the future.

Co-authorship network of co-authors of P.M.J. Haffmans

This figure shows the co-authorship network connecting the top 25 collaborators of P.M.J. Haffmans. A scholar is included among the top collaborators of P.M.J. Haffmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M.J. Haffmans. P.M.J. Haffmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mannesse, Cyndie K., Paul A. F. Jansen, Rob J. van Marum, et al.. (2013). Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: A cross-sectional study. Maturitas. 76(4). 357–363. 43 indexed citations
2.
Blom, Marc B.J., Philip Spinhoven, Tonko Hoffman, et al.. (2007). Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. Journal of Affective Disorders. 104(1-3). 119–126. 81 indexed citations
3.
Dorresteijn, Lucille D.A., et al.. (2007). Rivastigmine in Wernicke-Korsakoff's syndrome: Five patients with rivastigmine showed no more improvement than five patients without rivastigmine. Alcohol and Alcoholism. 43(1). 70–72. 11 indexed citations
4.
Haffmans, P.M.J., et al.. (2006). Comparing running therapy with physiotraining therapy in the treatment of mood disorders. Acta Neuropsychiatrica. 18(3-4). 173–176. 8 indexed citations
5.
Booij, Linda, Willem van der Does, P.M.J. Haffmans, & Wim J. Riedel. (2005). Acute tryptophan depletion in depressed patients treated with a selective serotonin–noradrenalin reuptake inhibitor: Augmentation of antidepressant response?. Journal of Affective Disorders. 86(2-3). 305–311. 14 indexed citations
6.
Booij, Linda, Willem van der Does, P.M.J. Haffmans, Philip Spinhoven, & Richard J. McNally. (2005). Acute tryptophan depletion as a model of depressive relapse. The British Journal of Psychiatry. 187(2). 148–154. 52 indexed citations
7.
Duivenvoorden, Hugo J., et al.. (2004). Sodium valproate in aggressive behaviour in dementia: a twelve‐week open label follow‐up study. International Journal of Geriatric Psychiatry. 19(4). 305–312. 22 indexed citations
8.
Haffmans, P.M.J., et al.. (2001). Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study. International Journal of Geriatric Psychiatry. 16(1). 106–110. 71 indexed citations
9.
Hoencamp, Erik, et al.. (2001). A 3.5-year naturalistic follow-up study of depressed out-patients. Journal of Affective Disorders. 66(2-3). 267–271. 13 indexed citations
10.
Haffmans, P.M.J., et al.. (2000). Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial. Schizophrenia Research. 46(2-3). 97–105. 34 indexed citations
11.
Hoencamp, Erik, et al.. (2000). Lithium Augmentation of Venlafaxine: An Open-Label Trial. Journal of Clinical Psychopharmacology. 20(5). 538–543. 26 indexed citations
12.
Haffmans, P.M.J., et al.. (2000). Is aggressive behaviour influenced by the use of a behaviour rating scale in patients in a psychogeriatric nursing home?. International Journal of Geriatric Psychiatry. 15(2). 108–111. 19 indexed citations
13.
Haffmans, P.M.J., et al.. (2000). Venlafaxine Serum Levels and CYP2D6 Genotype. Therapeutic Drug Monitoring. 22(2). 202–208. 102 indexed citations
14.
Brink, Wim van den, S. Tuinier, W.M.A. Verhoeven, et al.. (1999). NEU volume 11 issue 1 Cover and Front matter. Acta Neuropsychiatrica. 11(1). f1–f4. 1 indexed citations
15.
Hoencamp, Erik, et al.. (1998). A historical comparison of four antidepressants. European Neuropsychopharmacology. 8. S165–S165. 1 indexed citations
16.
Haffmans, P.M.J., et al.. (1997). Effect of a Program of Diverse Activities on Disturbed Behavior in Three Severely Demented Patients. International Psychogeriatrics. 9(4). 423–430. 16 indexed citations
17.
Haffmans, P.M.J., L. Timmerman, & C.A.L. Hoogduin. (1996). Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients. International Clinical Psychopharmacology. 11(3). 157–164. 41 indexed citations
18.
Haffmans, P.M.J., et al.. (1995). Tranylcypromine in Narcolepsy. Pharmacopsychiatry. 207(3). 98–100. 9 indexed citations
19.
Nolen, Willem A., P.M.J. Haffmans, Paul F. Bouvy, & Hugo J. Duivenvoorden. (1993). Monoamine oxidase inhibitors in resistant major depression. Journal of Affective Disorders. 28(3). 189–197. 42 indexed citations
20.
Nolen, Willem A., P.M.J. Haffmans, Paul F. Bouvy, & Hugo J. Duivenvoorden. (1993). Hypnotics as concurrent medication in depression. Journal of Affective Disorders. 28(3). 179–188. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.C. Ballenger Breakdown of academic impact, for papers by Nicholas DeMartinis Breakdown of academic impact, for papers by Anthony S. Hale Breakdown of academic impact, for papers by Maurizio Fava Breakdown of academic impact, for papers by Jun Ishigooka Breakdown of academic impact, for papers by Peter D. Londborg Breakdown of academic impact, for papers by Ion Anghelescu Breakdown of academic impact, for papers by J M Perel Breakdown of academic impact, for papers by Charles S. Wilcox Breakdown of academic impact, for papers by Gustavo Kinrys
Rankless by CCL
2026